已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Use of bevacizumab before or after radiotherapy increases the risk of fistula formation in patients with cervical cancer

医学 贝伐单抗 放射治疗 瘘管 宫颈癌 倾向得分匹配 外科 近距离放射治疗 回顾性队列研究 比例危险模型 癌症 内科学 化疗
作者
Nalee Kim,Seo Hee Choi,Jee Suk Chang,Young Tae Kim,Sang Wun Kim,Gun Min Kim,Yong Bae Kim
出处
期刊:International Journal of Gynecological Cancer [BMJ]
卷期号:31 (1): 59-65 被引量:15
标识
DOI:10.1136/ijgc-2020-002031
摘要

Several reports have documented the risk of fistula formation after bevacizumab in patients previously treated with radiation therapy. The aim of this study was to investigate the risk of fistula formation with bevacizumab and radiotherapy compared with radiotherapy alone.We retrospectively analyzed patients with stage I-IV cervical cancer between January 2013 and December 2018. Patients who had a history of pelvic radiotherapy, who were treated with intracavitary brachytherapy alone, received radiotherapy at another hospital, received concurrent bevacizumab and radiotherapy, or had missing follow-up data or a short follow-up period (<6 months) were excluded. The fistula rates were compared between the groups using the Cox proportional hazards model and propensity score analyses.A total of 302 patients were included in the study: 249 patients were treated with definitive or adjuvant radiotherapy, and 53 patients were treated with radiotherapy before or after bevacizumab. With a median follow-up of 35.9 (IQR 22.8-53.5) months, the 3 year cumulative fistula incidence rate was significantly higher in the radiotherapy + bevacizumab group than in the radiotherapy group (27.0% vs 3.0%, p<0.001). Bevacizumab administration was significantly associated with fistula formation in the multivariable adjusted model (HR 4.76, 95% CI 1.71 to 13.23) and three propensity score adjusted model (all p<0.05). Biologically equivalent dose in 2 Gy fractions for 2 cc of the rectum more than 76 Gy was also associated with fistula formation (HR 4.30, 95% CI 1.52 to 12.18). Additionally, a 10 month interval between radiotherapy and bevacizumab reduced the incidence of fistula formation in the radiotherapy + bevacizumab group (p=0.032).In patients with cervical cancer treated with pelvic radiotherapy, the addition of bevacizumab substantially increased the risk of fistula formation. Physicians should perform pelvic radiotherapy in combination with bevacizumab with caution; moreover, close monitoring for fistula formation is warranted in these patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
shuhaha完成签到,获得积分10
1秒前
wang完成签到 ,获得积分10
2秒前
轩海完成签到 ,获得积分10
6秒前
科研通AI2S应助lukybag采纳,获得30
8秒前
小凯完成签到 ,获得积分10
9秒前
大仙完成签到,获得积分20
9秒前
11秒前
ngg完成签到 ,获得积分10
11秒前
寒冷涵蕾发布了新的文献求助10
12秒前
迢迢笙箫完成签到,获得积分10
13秒前
holmes发布了新的文献求助20
13秒前
乐乐应助科研通管家采纳,获得10
18秒前
小二郎应助科研通管家采纳,获得10
18秒前
共享精神应助科研通管家采纳,获得10
18秒前
斯文败类应助科研通管家采纳,获得30
19秒前
科研通AI2S应助科研通管家采纳,获得30
19秒前
19秒前
领导范儿应助科研通管家采纳,获得10
19秒前
祖宁完成签到,获得积分10
19秒前
Nos_Edan发布了新的文献求助50
21秒前
慕子默完成签到,获得积分10
21秒前
自然的含蕾完成签到 ,获得积分10
24秒前
hank完成签到,获得积分10
28秒前
小蘑菇应助ssk采纳,获得10
29秒前
holmes完成签到,获得积分10
31秒前
鬼见愁应助林一采纳,获得10
32秒前
义气高丽完成签到 ,获得积分10
32秒前
32秒前
33秒前
吃不饱星球球长完成签到,获得积分0
34秒前
1111完成签到 ,获得积分10
37秒前
37秒前
小小莫完成签到 ,获得积分10
37秒前
百浪多息完成签到,获得积分10
37秒前
一一一多完成签到 ,获得积分10
38秒前
百浪多息发布了新的文献求助10
40秒前
江望雪完成签到 ,获得积分10
43秒前
灵巧的绮菱完成签到 ,获得积分10
43秒前
W123完成签到,获得积分10
45秒前
kaka完成签到,获得积分0
45秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
Very-high-order BVD Schemes Using β-variable THINC Method 568
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3136953
求助须知:如何正确求助?哪些是违规求助? 2787893
关于积分的说明 7783824
捐赠科研通 2443962
什么是DOI,文献DOI怎么找? 1299536
科研通“疑难数据库(出版商)”最低求助积分说明 625464
版权声明 600954